These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 34650909

  • 1. LncRNA SLCO4A1-AS1 Accelerates Growth and Metastasis of Gastric Cancer via Regulation of the miR-149/XIAP Axis.
    Fang Y, Sun B, Gao J, Huang Y, Wang C.
    Front Oncol; 2021; 11():683256. PubMed ID: 34650909
    [Abstract] [Full Text] [Related]

  • 2. SLCO4A1-AS1 Facilitates the Malignant Phenotype via miR-149-5p/STAT3 Axis in Gastric Cancer Cells.
    Li Q, Zhang D, Wang H, Xie J, Peng L, Peng Y, Zheng X, Jiang J.
    J Oncol; 2021; 2021():1698771. PubMed ID: 34712324
    [Abstract] [Full Text] [Related]

  • 3. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Yang Y, Wang F, Huang H, Zhang Y, Xie H, Men T.
    Onco Targets Ther; 2019; 12():1351-1358. PubMed ID: 30863101
    [Abstract] [Full Text] [Related]

  • 4. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.
    Chen YL, Liu YN, Lin YT, Tsai MF, Wu SG, Chang TH, Hsu CL, Wu HD, Shih JY.
    J Biomed Sci; 2023 Sep 19; 30(1):80. PubMed ID: 37726723
    [Abstract] [Full Text] [Related]

  • 5. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J, Han Z, Sun Z, Wang Y, Zheng M, Song C.
    J Exp Clin Cancer Res; 2018 Sep 10; 37(1):222. PubMed ID: 30201010
    [Abstract] [Full Text] [Related]

  • 6. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway.
    Mao J, Gao W, Xue L, Wang J, Zhao L.
    Int J Lab Hematol; 2021 Oct 10; 43(5):1050-1061. PubMed ID: 33683013
    [Abstract] [Full Text] [Related]

  • 7. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis.
    Zhang J, Shen Y, Ma D, Li Z, Zhang Z, Jin W.
    Open Med (Wars); 2022 Oct 10; 17(1):253-265. PubMed ID: 35233463
    [Abstract] [Full Text] [Related]

  • 8. LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1.
    Wu K, Xu T, Song X, Shen J, Zheng S, Zhang L, Tao G, Jiang B.
    Lab Invest; 2021 Jul 10; 101(7):908-920. PubMed ID: 33958701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
    Wu F, Gao H, Liu K, Gao B, Ren H, Li Z, Liu F.
    Onco Targets Ther; 2019 Jul 10; 12():657-667. PubMed ID: 30705594
    [Abstract] [Full Text] [Related]

  • 11. SLCO4A1-AS1 triggers the malignant behaviours of melanoma cells via sponging miR-1306-5p to enhance PCGF2.
    Wang K, Li M, Duan H, Fan M, Xu C, Yu F.
    Exp Dermatol; 2022 Aug 10; 31(8):1220-1233. PubMed ID: 35427425
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
    Ma HW, Xi DY, Ma JZ, Guo M, Ma L, Ma DH, Li PW, Guo CA.
    Dis Markers; 2020 Aug 10; 2020():8140989. PubMed ID: 32051698
    [Abstract] [Full Text] [Related]

  • 16. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
    Ding Y, Huang Y, Zhang F, Gong L, Liang C, Ding K, He X, Ding X, Chen Y.
    J Transl Med; 2023 Nov 26; 21(1):854. PubMed ID: 38008726
    [Abstract] [Full Text] [Related]

  • 17. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y, Ma Z, Liu W, Yu T, Yan C, Jiang H, Tian S, Xu T, Shu Y.
    Mol Cancer; 2020 Jan 10; 19(1):6. PubMed ID: 31924214
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.